| Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene S Pennacchietti, P Michieli, M Galluzzo, M Mazzone, S Giordano, ... Cancer cell 3 (4), 347-361, 2003 | 1591 | 2003 |
| A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family C Ponzetto, A Bardelli, Z Zhen, F Maina, P dalla Zonca, S Giordano, ... Cell 77 (2), 261-271, 1994 | 1229 | 1994 |
| Drug development of MET inhibitors: targeting oncogene addiction and expedience PM Comoglio, S Giordano, L Trusolino Nature reviews Drug discovery 7 (6), 504-516, 2008 | 969 | 2008 |
| Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer A Bardelli, S Corso, A Bertotti, S Hobor, E Valtorta, G Siravegna, ... Cancer discovery 3 (6), 658-673, 2013 | 712 | 2013 |
| The dual roles of NRF2 in cancer S Menegon, A Columbano, S Giordano Trends in molecular medicine 22 (7), 578-593, 2016 | 665 | 2016 |
| Expression of the Met/HGF receptor in normal and neoplastic human tissues. MF Di Renzo, RP Narsimhan, M Olivero, S Bretti, S Giordano, E Medico, ... Oncogene 6 (11), 1997-2003, 1991 | 643 | 1991 |
| Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer. MF Di Renzo, M Olivero, A Giacomini, H Porte, E Chastre, L Mirossay, ... Clinical cancer research: an official journal of the American Association …, 1995 | 636 | 1995 |
| Tyrosine kinase receptor indistinguishable from the c-met protein S Giordano, C Ponzetto, MFD Renzo, CS Cooper, PM Comoglio Nature 339 (6220), 155-156, 1989 | 596 | 1989 |
| From single-to multi-target drugs in cancer therapy: when aspecificity becomes an advantage S Giordano, A Petrelli Current medicinal chemistry 15 (5), 422-432, 2008 | 583 | 2008 |
| The endophilin–CIN85–Cbl complex mediates ligand-dependent downregulation of c-Met A Petrelli, GF Gilestro, S Lanzardo, PM Comoglio, N Migone, S Giordano Nature 416 (6877), 187-190, 2002 | 558 | 2002 |
| The semaphorin 4D receptor controls invasive growth by coupling with Met S Giordano, S Corso, P Conrotto, S Artigiani, G Gilestro, D Barberis, ... Nature cell biology 4 (9), 720-724, 2002 | 548 | 2002 |
| Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene C Ghigna, S Giordano, H Shen, F Benvenuto, F Castiglioni, PM Comoglio, ... Molecular cell 20 (6), 881-890, 2005 | 464 | 2005 |
| Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas MF Di Renzo, M Olivero, T Martone, A Maffe, P Maggiora, A De Stefani, ... Oncogene 19 (12), 1547-1555, 2000 | 431 | 2000 |
| MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? S Giordano, A Columbano Hepatology 57 (2), 840-847, 2013 | 423 | 2013 |
| Negative receptor signalling I Dikic, S Giordano Current opinion in cell biology 15 (2), 128-135, 2003 | 412 | 2003 |
| Cancer therapy: can the challenge be MET? S Corso, PM Comoglio, S Giordano Trends in molecular medicine 11 (6), 284-292, 2005 | 341 | 2005 |
| Sema4D induces angiogenesis through Met recruitment by Plexin B1 P Conrotto, D Valdembri, S Corso, G Serini, L Tamagnone, PM Comoglio, ... Blood 105 (11), 4321-4329, 2005 | 323 | 2005 |
| Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages JR Sierra, S Corso, L Caione, V Cepero, P Conrotto, A Cignetti, ... The Journal of experimental medicine 205 (7), 1673-1685, 2008 | 317 | 2008 |
| Biosynthesis of the protein encoded by the c-met proto-oncogene. S Giordano, MF Di Renzo, RP Narsimhan, CS Cooper, C Rosa, ... Oncogene 4 (11), 1383-1388, 1989 | 306 | 1989 |
| Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy JR Sierra, V Cepero, S Giordano Molecular cancer 9, 1-13, 2010 | 287 | 2010 |
